Significant Ownership of Andera Partners
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Andera Partners focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Stephane Bergez - By Stephane Bergez, Managing Partner
- Manager location
- Paris
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Andera Partners with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Andera Partners
Significant Ownership of Andera Partners
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVA | Inventiva S.A. | Ordinary Shares, nominal value Euro 0.01 per share | 7.7% | $80,593,658 | +$10,381,814 | 14,114,476 | +15% | Andera Partners | 31 Dec 2025 |
| EVOMMUNE, INC. | Common Stock, $0.0001 par value per share | 6% | 1,897,362 | Andera Partners | 07 Nov 2025 | ||||
| MLYS | MINERALYS THERAPEUTICS, INC. | Common Stock, $0.0001 par value per share | 4.2% | $39,747,075 | 2,765,976 | Andera Partners | 30 Jun 2025 |
Schedules 13D/G Reported by Andera Partners:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.